Early Effects of Hyperbaric Oxygen on Inducible Nitric Oxide Synthase Activity/Expression in Lymphocytes of Type 1 Diabetes Patients: A Prospective Pilot Study

Table 1

Anthropometric and metabolic parameters of T1DM patients. Results are presented as mean ± SEM: HBOT: hyperbaric oxygen therapy; T1DM: type 1 diabetes mellitus; BMI: body mass index; HbA1c: glycosylated hemoglobin; WBC: white blood cells; RBC: red blood cells; TG: triglyceride.

Parameter	Mean ± SE (min–max)	Reference range
Age (years)	63 ± 2.1 (50–80)
Weight (kg)	82.6 ± 2.9 (62–99)
High (m)	1.74 ± 0.02 (1.6–1.8)
BMI (kg/m)	27.4 ± 0.9 (21.8–33.7)
HbA1c (%)	8.6 ± 0.08 (6.1–12.7)	4.8–5.9
Hemoglobin (g/L)	136 ± 3.4 (111–169)	120–175
Hematocrit (%)	40 ± 0.1 (30–50)	35–50
WBC (×10^3/L)	8.3 ± 0.5 (3.4–11.3)	3.5–10.5
RBC (×10^6/L)	4.7 ± 0.2 (3.9–6.6)	3.9–5.7
Platelets (×10^3/L)	264 ± 26.7 (127–393)	150–450
Cholesterol (mmol/L)	5 ± 0.4 (3.25–7.9)	5-6.2
TG (mmol/L)	2.3 ± 0.4 (0.7–4.0)	1.7–2.2